SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Chemicals spurts on initiating the process of debt restructuring

24 Jun 2013 Evaluate

Orchid Chemicals & Pharmaceuticals is currently trading at Rs 51.35, up by 0.80 points or 1.58% from its previous closing of Rs 50.55 on the BSE.

The scrip opened at Rs 48.00 and has touched a high and low of Rs 52.55 and Rs 48.00 respectively. So far 112388 shares were traded on the counter.

The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 131.85 on 20-Jul-2012 and a 52 week low of Rs 46.75 on 13-Jun-2013.

Last one week high and low of the scrip stood at Rs 58.65 and Rs 47.80 respectively. The current market cap of the company is Rs 361.42 crore.

The promoters holding in the company stood at 32.28% while Institutions and Non-Institutions held 10.17 % and 52.98 % respectively.

Orchid Chemicals and Pharmaceuticals has initiated the process of restructuring its debt due to continuing liquidity constraints and pressure on operations. Accordingly the company has made reference to the Corporate Debt Restructuring Cell (CDR Cell) through State Bank of India (SBI).

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

549.80 -20.70 (-3.63%)
20-Apr-2026 14:37 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.90
Dr. Reddys Lab 1235.10
Cipla 1232.95
Zydus Lifesciences 936.50
Lupin 2327.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×